143 related articles for article (PubMed ID: 23437314)
1. A novel selection marker for efficient DNA cloning and recombineering in E. coli.
Jang CW; Magnuson T
PLoS One; 2013; 8(2):e57075. PubMed ID: 23437314
[TBL] [Abstract][Full Text] [Related]
2. Plasmid selection in Escherichia coli using an endogenous essential gene marker.
Goh S; Good L
BMC Biotechnol; 2008 Aug; 8():61. PubMed ID: 18694482
[TBL] [Abstract][Full Text] [Related]
3. The antibiotic resistance-free mammalian expression plasmid vector pPAL for development of third generation vaccines.
Alcolea PJ; Alonso A; Larraga V
Plasmid; 2019 Jan; 101():35-42. PubMed ID: 30529129
[TBL] [Abstract][Full Text] [Related]
4. A pestivirus DNA vaccine based on a non-antibiotic resistance Escherichia coli essential gene marker.
El-Attar LM; Scott S; Goh S; Good L
Vaccine; 2012 Feb; 30(9):1702-9. PubMed ID: 22212129
[TBL] [Abstract][Full Text] [Related]
5. Use of FabV-Triclosan Plasmid Selection System for Efficient Expression and Production of Recombinant Proteins in Escherichia coli.
Ali SA; Chew YW; Omar TC; Azman N
PLoS One; 2015; 10(12):e0144189. PubMed ID: 26642325
[TBL] [Abstract][Full Text] [Related]
6. FabV/Triclosan Is an Antibiotic-Free and Cost-Effective Selection System for Efficient Maintenance of High and Medium-Copy Number Plasmids in Escherichia coli.
Ali SA; Chew YW
PLoS One; 2015; 10(6):e0129547. PubMed ID: 26057251
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and mechanism of triclosan resistance in Escherichia coli isolated from urine samples in Wenzhou, China.
Zeng W; Xu W; Xu Y; Liao W; Zhao Y; Zheng X; Xu C; Zhou T; Cao J
Antimicrob Resist Infect Control; 2020 Oct; 9(1):161. PubMed ID: 33008474
[TBL] [Abstract][Full Text] [Related]
8. Reduced Susceptibility to Antiseptics Is Conferred by Heterologous Housekeeping Genes.
Tansirichaiya S; Reynolds LJ; Cristarella G; Wong LC; Rosendahl K; Roberts AP
Microb Drug Resist; 2018 Mar; 24(2):105-112. PubMed ID: 28604259
[TBL] [Abstract][Full Text] [Related]
9. ucFabV Requires Functional Reductase Activity to Confer Reduced Triclosan Susceptibility in Escherichia coli.
Fischer TL; White RJ; Mares KF; Molnau DE; Donato JJ
J Mol Microbiol Biotechnol; 2015; 25(6):394-402. PubMed ID: 26683704
[TBL] [Abstract][Full Text] [Related]
10. Signature gene expression profile of triclosan-resistant Escherichia coli.
Yu BJ; Kim JA; Pan JG
J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062
[TBL] [Abstract][Full Text] [Related]
11. Effects of lysine 2-hydroxyisobutyrylation on bacterial FabI activity and resistance to triclosan.
Zheng Y; Dong H; Bai X; Cui H; Li MJ; Wu HY; Zhang K
Biochimie; 2021 Mar; 182():197-205. PubMed ID: 33485933
[TBL] [Abstract][Full Text] [Related]
12. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
[TBL] [Abstract][Full Text] [Related]
13. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
Massengo-Tiassé RP; Cronan JE
J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents.
Seefeld MA; Miller WH; Newlander KA; Burgess WJ; Payne DJ; Rittenhouse SF; Moore TD; DeWolf WE; Keller PM; Qiu X; Janson CA; Vaidya K; Fosberry AP; Smyth MG; Jaworski DD; Slater-Radosti C; Huffman WF
Bioorg Med Chem Lett; 2001 Sep; 11(17):2241-4. PubMed ID: 11527706
[TBL] [Abstract][Full Text] [Related]
15. Construction of a broad host range cloning vector conferring triclosan resistance.
Kagle J; Hay AG
Biotechniques; 2002 Sep; 33(3):490, 492. PubMed ID: 12238756
[No Abstract] [Full Text] [Related]
16. Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration.
Cranenburgh RM; Hanak JA; Williams SG; Sherratt DJ
Nucleic Acids Res; 2001 Mar; 29(5):E26. PubMed ID: 11222777
[TBL] [Abstract][Full Text] [Related]
17. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
[TBL] [Abstract][Full Text] [Related]
18. In vivo cloning by homologous recombination in yeast using a two-plasmid-based system.
Degryse E; Dumas B; Dietrich M; Laruelle L; Achstetter T
Yeast; 1995 Jun; 11(7):629-40. PubMed ID: 7483836
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases.
Stone GW; Zhang Q; Castillo R; Doppalapudi VR; Bueno AR; Lee JY; Li Q; Sergeeva M; Khambatta G; Georgopapadakou NH
Antimicrob Agents Chemother; 2004 Feb; 48(2):477-83. PubMed ID: 14742198
[TBL] [Abstract][Full Text] [Related]
20. A Novel Nonantibiotic,
Terrinoni M; Nordqvist SL; Källgård S; Holmgren J; Lebens M
Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29222103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
